Incidence of Topical Tacrolimus Adverse Effects in Chronic Skin Disease
Open Access
- 1 January 2019
- journal article
- editorial
- Published by XMLink in Annals of Dermatology
- Vol. 31 (1) , 90-92
Abstract
Park HJ, et al. Ann Dermatol. 2019 Feb;31(1):90-92. https://doi.org/10.5021/ad.2019.31.1.90Keywords
This publication has 9 references indexed in Scilit:
- Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritusAdvances in Dermatology and Allergology, 2013
- A comparison of neuropeptide expression in skin with allergic contact dermatitis in human and mouseInternational Journal of Dermatology, 2012
- Potential New Indications of Topical Calcineurin InhibitorsDermatology, 2007
- The safety of tacrolimus ointment for the treatment of atopic dermatitis: a reviewBritish Journal of Dermatology, 2007
- Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skinBritish Journal of Dermatology, 2007
- Substance P may play a part during depigmentation in vitiligo. A pilot study.Journal of the European Academy of Dermatology and Venereology, 2003
- Markers for vitiligo related neuropeptides in human skin nerve fibers.2000
- Neuropeptide and neuronal marker studies in vitiligoBritish Journal of Dermatology, 1994
- Substance P and rosaceaJournal of the American Academy of Dermatology, 1993